Stridex

A drugstore container of medicated pads might seem an odd thing for a national museum to preserve, yet the Smithsonian holds one, because the object marks a genuine shift in how ordinary people dealt with breakouts. The format was the innovation as much as the chemistry: cotton rounds pre-soaked in active solution, with a deliberately coarse weave so that wiping the face lifted off visible grime, a tactile proof-of-work that did as much for the marketing as for the skin.

The chemistry settled, over the decades, on a beta-hydroxy acid that dissolves the oily debris clogging pores from the inside, offered across the range up to the two-percent ceiling permitted without a prescription, with strengths as low as half a percent for reactive skin and a separate benzoyl-peroxide variant for those who want it. The single most consequential reformulation was subtraction rather than addition: the brand eventually pulled the alcohol that made earlier astringent products sting, and built its later identity around effectiveness without the burn. Corporate custody moved more than once, passing through a large pharmaceutical portfolio before landing with its current owner in the mid-1990s, where it has stayed.

The modern twist is that the product found a second life it was never designed for. Online skincare communities, hunting for cheap, no-frills actives, rediscovered the alcohol-free, fragrance-free two-percent pads and championed them as a fraction-of-the-price alternative to boutique acid toners doing the identical job. The one caveat worth flagging is variant confusion: not every product in the line is the gentle version, and some still carry menthol or fragrance that can irritate sensitive skin, so the label genuinely matters. Read it, and you have one of the better-value exfoliants the drugstore sells, evidence that effective skincare need not be new or expensive.

Sources:[1][2][3]